CANNARA BIOTECH INC (LOVE.CA) Stock Balance Sheet
TSX-V:LOVE - TSX Venture Exchange - CA13765U2002 - Common Stock - Currency: CAD
| MRQ (2024-11-30) | 2024 (2024-8-31) | 2023 (2023-8-31) | 2022 (2022-8-31) | 2021 (2021-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 10.26M | 6.62M | 4.27M | 12.11M | 8.16M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 12.93M | 13.04M | 10.59M | 8.62M | 2.97M | |||
| Inventories | 41.74M | 40.07M | 33.77M | 18.98M | 7.41M | |||
| Other Current Assets | 8.31M | 7.74M | 3.06M | 1.28M | 708.80K | |||
| Total Current Assets | 73.25M | 67.47M | 51.70M | 40.99M | 19.25M | |||
| Non-Current Assets | ||||||||
| PPE Net | 85.88M | 84.94M | 89.44M | 83.40M | 71.75M | |||
| Intangibles | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 1.87M | 2.31M | 389.70K | 1.22M | 952.90K | |||
| Total Non-Current Assets | 87.76M | 87.25M | 89.83M | 84.63M | 72.78M | |||
| TOTAL ASSETS | 161.00M | 154.72M | 141.52M | 125.62M | 92.02M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 6.76M | 6.26M | 3.00M | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 9.20M | 3.25M | 3.04M | 2.19M | 529.00K | |||
| Accrued Expenses | 8.27M | 7.79M | 1.57M | 826.60K | 72.30K | |||
| Accounts Payable | 11.85M | 9.58M | 13.41M | 8.80M | 6.19M | |||
| Other Current Liabilities | 425.40K | 134.80K | 160.90K | 45.20K | 41.60K | |||
| Total Current Liabilities | 36.50M | 27.00M | 21.18M | 11.86M | 6.83M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 33.01M | 38.82M | 39.74M | 46.20M | 20.37M | |||
| Other Non-Current Liabilities | 915.90K | 945.00K | 856.80K | 816.50K | 705.10K | |||
| Total Non-Current Liabilities | 33.92M | 39.77M | 40.60M | 47.02M | 21.07M | |||
| TOTAL LIABILITIES | 70.43M | 66.77M | 61.78M | 58.88M | 27.91M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -10.59M | -12.90M | -19.34M | -26.30M | -28.61M | |||
| Additional Paid In Capital | 12.65M | 12.33M | 10.35M | 9.72M | 9.41M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 88.52M | 88.52M | 88.80M | 83.30M | 83.21M | |||
| Other Shareholders' Equity | N/A | 0.00 | -69.30K | 15.10K | 100.10K | |||
| Shares Outstanding | 90.02M | 90.02M | 90.31M | 87.70M | 87.65M | |||
| Tangible Book Value per Share | 1.01 | 0.98 | 0.88 | 0.76 | 0.73 | |||
| Total Shareholders' Equity | 90.58M | 87.95M | 79.74M | 66.74M | 64.12M | |||
| TOTAL LIABILITIES AND EQUITY | 161.00M | 154.72M | 141.52M | 125.62M | 92.02M | |||
| Statistics | ||||||||
| Debt/Equity | 0.44 | 0.51 | 0.54 | 0.69 | 0.32 | |||
| Current Ratio | 2.01 | 2.50 | 2.44 | 3.46 | 2.82 | |||
| Return On Assets (ROA) | 4.12% | 4.16% | 4.91% | 1.84% | -1.66% | |||
| Return On Equity (ROE) | 7.33% | 7.32% | 8.71% | 3.45% | -2.38% | |||
All data in CAD , ROIC based on taxRate of 0.28